Draw
|
Currency :
Structure Search
AG0038S4
357-70-0 | Galanthamine
AG0038S4
SDS
COATIP
This product is typically in stock.Please contact us for
quotation.
Request For Quotation
- mg
- g
- kg
- ml
- L
No data
- mg
- g
- kg
- ml
- L
No data
No data
| CAS Number | 357-70-0 |
| Catalog Number | AG0038S4(AGN-PC-0RB8F4) |
| Chemical Name | Galanthamine |
| IUPAC Name | (1S,12S,14R)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol |
| InChI | InChI=1S/C17H21NO3/c1-18-8-7-17-6-5-12(19)9-14(17)21-16-13(20-2)4-3-11(10-18)15(16)17/h3-6,12,14,19H,7-10H2,1-2H3/t12-,14-,17-/m0/s1 |
| InChI Key | ASUTZQLVASHGKV-JDFRZJQESA-N |
| MDL Number | MFCD00867189 |
| Molecular Formula | C17H21NO3 |
| Molecular Weight | 287.3535 |
| NSC Number | 759861 |
| SMILES | COc1ccc2c3c1O[C@@H]1[C@@]3(CCN(C2)C)C=C[C@@H](C1)O |
| UNII | 0D3Q044KCA |
| Synonyms | Galantamin,
Galantamine,
Galanthamine,
Galanthamine Hydrobromide,
Lycoremine,
Nivalin,
Nivaline,
Razadyne,
Reminyl,
galanthamine,
Galantamine,
357-70-0,
(-)-Galanthamine,
Lycoremin,
Lycoremine,
Galantamin,
Jilkon,
Galantamina,
Galanthaminum,
Nivalin,
Razadyne,
Razadyne ER,
Galantaminum [INN-Latin],
Galantamina [INN-Spanish],
UNII-0D3Q044KCA,
NSC 100058,
BRN 0093736,
HSDB 7361,
Reminyl (TN),
CHEMBL659,
0D3Q044KCA,
(4aS,6R,8aS)-4a,5,9,10,11,12-Hexahydro-3-methoxy-11-methyl-6H-benzofuro(3a,3,2-ef)(2)benzazepin-6-ol,
CHEBI:42944,
Galanthamine base,
Galanthamine HBr,
NCGC00017256-04,
Galantaminum,
(-)-Galantamine,
GNT,
Galantamine [USAN:INN],
6H-Benzofuro(3a,3,2-ef)(2)benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, (4aS,6R,8aS)-,
6H-Benzofuro[3a,3,2-ef][2]benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, (4aS,6R,8aS)-,
Galantamine (USAN/INN),
Bodamine,
Galantamine [USAN:INN:BAN],
SR-05000001783,
(-)Galanthamine,
1qti,
Galanthamine, 12,
(+/-)-Galantamine,
(+/-)-Galanthamine,
Spectrum_001271,
1dx6,
AC1L1TIM,
Prestwick0_000588,
Prestwick1_000588,
Prestwick2_000588,
Prestwick3_000588,
Spectrum3_001738,
Spectrum4_000839,
Spectrum5_001673,
Galantamine, (+/-)-,
Galanthamine, (+/-)-,
Probes1_000055,
Probes2_000395,
SCHEMBL2577,
DSSTox_CID_25606,
DSSTox_RID_80999,
DSSTox_GSID_45606,
BSPBio_000436,
BSPBio_003416,
KBioGR_001417,
KBioSS_001751,
4-27-00-02184 (Beilstein Handbook Reference),
BIDD:GT0517,
DivK1c_000590,
Galantamin(NSC 100058),
SPBio_002655,
BPBio1_000480,
GTPL6693,
SCHEMBL3293474,
DTXSID2045606,
ASUTZQLVASHGKV-JDFRZJQESA-,
BDBM10404,
CTK8F9985,
KBio1_000590,
KBio2_001751,
KBio2_004319,
KBio2_006887,
KBio3_002636,
ASUTZQLVASHGKV-JDFRZJQESA-N,
NINDS_000590,
HMS2089H03,
Pharmakon1600-01501202,
ZINC491073,
BCP28966,
KS-000000IN,
Tox21_110807,
AN-133,
CG0028,
MFCD00867189,
NSC759861,
AKOS015965330,
AM62710,
CCG-212961,
CS-1217,
DB00674,
MCULE-7156449246,
MCULE-7226205054,
NSC-759861,
SDCCGMLS-0066737.P001,
IDI1_000590,
SMP1_000131,
NCGC00017256-05,
NCGC00017256-11,
NCGC00024731-02,
AC-20240,
AJ-23165,
AN-44509,
CAS-357-70-0,
HY-76299,
LS-71039,
SBI-0051689.P002,
C08526,
D04292,
W-5162,
AB00053614-09,
AB00053614_10,
357G700,
SR-05000001783-4,
BRD-K49481516-004-03-5,
BRD-K49481516-004-04-3,
BRD-K49481516-004-09-2,
UNII-1T835Z585R component ASUTZQLVASHGKV-JDFRZJQESA-N,
(1S,12S,14R)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0;{1,12}.0;{6,17}]heptadeca-6,8,10(17),15-tetraen-14-ol,
(1S,12S,14R)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-6,8,10(17),15-tetraen-14-ol,
(1S,12S,14R)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol,
(4aS,6R,8aS)-3-methoxy-11-methyl-4a,5,9,10,11,12-hexahydro-6H-benzo[2,3]benzofuro[4,3-cd]azepin-6-ol,
(4aS,6R,8aS)-4a,5,9,10,11,12-Hexahydro-3-methoxy-11-methyl-6H-benzofurol[3a,3,2,-ef][2]benzazepin-6-ol,
23173-12-8,
6H-Benzofuro(3a,3,2-ef)(2)benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, (4aalpha,6beta,8ar*)-,
6H-Benzofuro(3a,3,2-ef)(2)benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, (4aR,6S,8aR)-rel-,
6H-Benzofuro[3a,3,2-ef][2]benzazepin-6-ol,4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, (4aS,6R,8aS)-,
InChI=1/C17H21NO3/c1-18-8-7-17-6-5-12(19)9-14(17)21-16-13(20-2)4-3-11(10-18)15(16)17/h3-6,12,14,19H,7-10H2,1-2H3/t12-,14-,17-/m0/s1,
Reminyl,
Nivaline,
Galanthamine hydrobromide,
Galantamine hydrobromide,
Razadyne (TN),
Nivalin (TN),
FURAGIN,
Razadyne ER (TN),
methoxy(methyl)[?]ol,
D0R9VR,
C17H21NO3,
UNII-1T835Z585R,
CID9651,
C17-H21-N-O3,
NSC100058,
1T835Z585R,
ACN-035451,
CS-O-01567,
1543B,
A1745,
A3422,
A3423,
D005702,
(4aS,6R,8aS)-4a,5,9,10,11,12-Hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-ol,
1672-88-4,
1953-04-4,
69353-21-5,
6H-Benzofuro(3a,3,2-ef)(2)benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-,
|
| Complexity | 440 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 3 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 287.152g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 21 |
| Hydrogen Bond Acceptor Count | 4 |
| Hydrogen Bond Donor Count | 1 |
| Isotope Atom Count | 0 |
| Molecular Weight | 287.359g/mol |
| Monoisotopic Mass | 287.152g/mol |
| Rotatable Bond Count | 1 |
| Topological Polar Surface Area | 41.9A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 1.8 |
GHS Hazard and Precautionary Statements
| Symbol: |  |
| Hazard Class | 6.1 |
| Hazard statements | H302 |
| Packing Group | Ⅱ |
| Precautionary statements | P280-P305+P351+P338 |
| UN Code | UN 2811 |
Certificate of Analysis
Lot Number
Related Research Chemicals
CERTIFICATE OF ANALYSIS
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
Analysis Data:
| Test: | Result: |
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited